NewLink Genetics Competitors and Similar CompaniesClear all
NewLink Genetics's competitors and similar companies include CytomX Therapeutics.
 NewLink Genetics NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases. |  CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | |
Founding Date | Founding Date 1999 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Ames, US HQ Austin, US Devens, US | Locations South San Francisco, US HQ |
Employees | Employees 2162% decrease | Employees 15815% increase |
Valuation ($) | Valuation ($) 33.2 m | Valuation ($) 78 m |
Financial | ||
Revenue (est.) | Revenue (est.) $230k (FY, 2021) | Revenue (est.) $76.2m (FY, 2025) |
Net income | Net income ($30.4m) (FY, 2021) | Net income ($17.4m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 45.2m | Total funding raised $ 132.4m |
For sources of this data, please see the company profile
View Company Profiles
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View company